NCT03883711 Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation
| NCT ID | NCT03883711 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 11,000 participants |
| Start Date | 2017-01-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 11,000 participants in total. It began in 2017-01-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
AMIPE is both a retrospective and prospective study which was designed in order to collect data of patients with acute coronary syndromes and myocardial injury and to improve the knowledge about these conditions.
Eligibility Criteria
Inclusion Criteria: * Patient aged \> 18 years old * Acute coronary syndrome or myocardial injury * Written informed consent Exclusion Criteria: * under age or not able to give informed consent
Contact & Investigator
Carmine Pizzi, Dr
PRINCIPAL INVESTIGATOR
University of Bologna, Cardiology Department
Frequently Asked Questions
Who can join the NCT03883711 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03883711 currently recruiting?
Yes, NCT03883711 is actively recruiting participants. Contact the research team at carmine.pizzi@unibo.it for enrollment information.
Where is the NCT03883711 trial being conducted?
This trial is being conducted at Bologna, Italy, Bologna, Italy, Forlì, Italy.
Who is sponsoring the NCT03883711 clinical trial?
NCT03883711 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Carmine Pizzi, Dr at University of Bologna, Cardiology Department. The trial plans to enroll 11,000 participants.